<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2572">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04354818</url>
  </required_header>
  <id_info>
    <org_study_id>2020-04-CORIA</org_study_id>
    <nct_id>NCT04354818</nct_id>
  </id_info>
  <brief_title>Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)</brief_title>
  <acronym>CORIA</acronym>
  <official_title>Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kirby Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St Vincent's Hospital, Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Garvan Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Westmead Hospital, Sydney, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blacktown Hospital, Sydney, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Holdsworth House Medical Practice</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal North Shore Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Melanoma Institute Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prince of Wales Hospital, Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer Institute NSW</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer Council New South Wales</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Positive Life NSW</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St George Hospital, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Liverpool Hospital, Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kirby Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CORIA is an observational cohort study of immunosuppressed populations who test positive for
      COVID-19. This includes people living with HIV, cancer, acquired immunodeficiency associated
      with other immunosuppressive therapy, primary immunodeficiency and recipients of a solid
      organ transplant. Participants will have routine clinical data collected with optional
      baseline collection and storage of a blood sample for storage . The study will be conducted
      in up to 30 sites within Australia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2020</start_date>
  <completion_date type="Anticipated">April 27, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 27, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>percentage of patients who required hospitalisation, developed severe illness (ICU admission) or died</measure>
    <time_frame>Day 28</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of patients who required hospitalisation, developed severe illness (ICU admission) or died</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>HIV-1-infection</condition>
  <condition>Cancer</condition>
  <condition>Primary Immune Deficiency Disorder</condition>
  <condition>Immunosuppression Disorders</condition>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>People living with HIV</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Recipients of Solid Organ Transplants</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>People Living with Cancer</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>People with acquired immunodeficiency</arm_group_label>
    <description>Patients with acquired immunodeficiency associated with other immunosuppressive therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>People with primary immunodeficiency</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Participants aged 18 years or older with a known condition affecting immune function
        (Primary Immune Deficiency, on Immunosuppressive Therapy, on Immune checkpoint inhibitors
        within 36 months of study enrolment, HIV infection, recipient of Solid Organ Transplant or
        diagnosis of Cancer within 36 months of study enrolment, excluding superficial basal cell
        and squamous cell carcinomas) presenting with clinical symptoms consistent with COVID-19 or
        a known contact to a confirmed case or known to be COVID-19 positive.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Presenting (in person or via telemedicine) for evaluation because they:

               -  Have clinical symptoms consistent with for COVID-19:

               -  Fever (≥ 37.8 °C) on examination OR patient reported fever (≥ 37.8 °C) or
                  feverishness (felt febrile but did not take temperature) OR any of, cough, sore
                  throat, shortness of breath, rhinorrhoea, headache, chills, generalise myalgia,
                  malaise, fatigue, confusion, diarrhea, nausea or vomiting

               -  Have been contacted because they have been identified as a contact to a confirmed
                  case

               -  Have been contacted and told they tested positive for COVID-19

          2. Have one of the following conditions affecting immune function:

               -  Known or suspected primary immunodeficiency, defined as a predisposition to
                  infection associated with an apparent or presumed deficit of immune function

               -  On immunosuppressive therapy

               -  Treatment with immune checkpoint inhibitors within 36 months of enrolment date

               -  HIV infection

               -  Diagnosis of cancer within 36 months of enrolment date, excluding superficial
                  basal cell and squamous cell carcinomas

               -  Solid organ transplantation

          3. For optional biobanking only, ability to provide informed consent

        Exclusion Criteria:

          -  Nil
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Polizzotto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kirby Institute UNSW</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Polizzotto, MD</last_name>
    <phone>+61 2 93850900</phone>
    <email>coria@kirby.unsw.edu.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Griselda Buckland</last_name>
    <phone>+61 2 93850900</phone>
    <email>coria@kirby.unsw.edu.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Barbara Withers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Sydney Doctors</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Baker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christopher Andersen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Blacktown Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2148</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Wei Chua</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St George Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Shir-Jing Ho</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Concord Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Brenadan Beaton</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holdsworth House Medical Practice</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mark Bloch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Melanoma Institute Australia</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Georgina Long</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nepean Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Man Yuk Ho</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>David Brown</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 16, 2020</study_first_submitted>
  <study_first_submitted_qc>April 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>July 26, 2020</last_update_submitted>
  <last_update_submitted_qc>July 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

